Drugs / Rocuronium
last change 3 days ago re-read 2 minutes ago

Rocuronium

Other / unclassified

Developed for
cardiac arrest · curariform drugs toxicity · acute respiratory distress syndrome · gallbladder disorder · newborn respiratory distress syndrome · pharyngitis · respiratory failure · appendicitis
+3 more · organophosphate poisoning · pediatric acute respiratory distress syndrome · urinary bladder cancer
Investigated by
Merck Sharp & Dohme LLC · Yonsei University · Seoul National University Hospital · Radboud University Medical Center · Seoul National University Bundang Hospital · Ain Shams University
+99 more · Asan Medical Center · Beth Israel Deaconess Medical Center · Brno University Hospital · Chonnam National University Hospital · Fondation Ophtalmologique Adolphe de Rothschild · Korea University Anam Hospital · Korea University Guro Hospital · Leiden University Medical Center · Massachusetts General Hospital · The Catholic University of Korea · The University of Texas Health Science Center, Houston · University Hospital Olomouc · University of Washington · AZ Sint-Jan AV · Air Force Military Medical University, China · Ajou University School of Medicine · Amsterdam UMC, location VUmc · Ankara City Hospital Bilkent · Azienda Ospedaliera di Padova · Bach Mai Hospital · Balgrist University Hospital · Beaumont Hospital · Brasilia University Hospital · Brigham and Women's Hospital · Central Hospital, Nancy, France · Centre Hospitalier Universitaire de la Réunion · Centro Hospitalar do Porto · Charles University, Czech Republic · Chulalongkorn University · Chun Song Youn · Clare Hayes-Bradley · Clinical Hospital Centre Zagreb · Federico II University · First Affiliated Hospital of Harbin Medical University · Fudan University · Gangnam Severance Hospital · General University Hospital, Prague · Go Eun Bae · Hanil General Hospital · Hanoi Medical University · Hanyang University Guri Hospital · Harbin Medical University · Hopital Foch · IGA - internal grant agency, Ministry of Health · IRCCS Azienda Ospedaliero-Universitaria di Bologna · Jaslok Hospital and Research Centre · Jiangsu HengRui Medicine Co., Ltd. · KDCHOT FN Brno · Kreiskrankenhaus Dormagen · MSD Belgium BVBA · MSD Korea Ltd. · Maharashtra University of Health Sciences · Malin Jonsson Fagerlund · Masaryk Hospital Usti nad Labem · Medical Center Haaglanden · Medical University of Bialystok · Medtronic - MITG · Memorial Sloan Kettering Cancer Center · Necker-Enfants Malades Hospital · Ostfold Hospital Trust · Palacky University · Peking Union Medical College Hospital · Peking University · Rigshospitalet, Denmark · SMG-SNU Boramae Medical Center · Sheba Medical Center · South Valley University · St. Anne's University Hospital Brno, Czech Republic · St. Vincent's Medical Center · Stony Brook University · São Paulo State University · TC Erciyes University · Taichung Armed Forces General Hospital · Tampere University Hospital · all 105 on the full record

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) ZEMURON 2008-08-28 fda.gov
Approved US (FDA) ZEMURON 1994-03-17 fda.gov

Trials 115 · started per year

today
US approved 1994
3
4
1
2
1
4
3
9
5
11
13
11
9
8
8
5
4
3
4
1
3
3
19941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 02 trials
Phase 0 NCT05619848 Oct → Dec 2022 lumbar spinal stenosis Zheng Guo Completed No outcome recorded
Phase 0 NCT05097508 Jun 2020 → Jun 2021 Ain Shams University Completed No outcome recorded
Phase 27 trials
Phase 2 NCT07252921 Oct → Dec 2025 Jiangsu HengRui Medicine Co., Ltd. Completed No outcome recorded
Phase 2 NCT03808077 Jan 2019 → Oct 2024 overdue prostate cancer Memorial Sloan Kettering Cancer Center Active not recruiting No outcome recorded
Phase 2 NCT03532178 Jan 2019 → Mar 2022 University of California, San Francisco Completed No outcome recorded
Phase 2 NCT02790164 May → Nov 2016 cardiac arrest Chun Song Youn Completed No outcome recorded
Phase 2 NCT02260258 Oct 2014 → May 2019 cardiac arrest Beth Israel Deaconess Medical Center Completed No outcome recorded
Phase 2 NCT01571908 Sep 2012 → Jul 2015 University Hospital, Geneva Completed No outcome recorded
Phase 2 NCT03519867 Aug 2004 → May 2005 Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 313 trials
Phase 3 NCT05725031 Apr 2023 → Feb 2024 Ain Shams University Completed No outcome recorded
Phase 3 NCT04709315 Oct 2020 → Jan 2021 South Valley University Unknown No outcome recorded
Phase 3 NCT03043157 Feb → Mar 2017 Brasilia University Hospital Completed No outcome recorded
Phase 3 NCT02000674 Dec 2013 → Jul 2016 Centre Hospitalier Universitaire de la Réunion Completed No outcome recorded
Phase 3 NCT00656799 Apr 2008 → Jul 2009 Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 3 NCT00559468 Dec 2006 → Mar 2007 Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 3 NCT00474253 Feb → Aug 2006 Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 3 NCT00421148 May 2005 → May 2006 Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 3 NCT00124722 Dec 2004 → Jul 2007 Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 3 NCT00124735 Oct 2004 → Aug 2007 Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 441 trials
Phase 4 NCT07650552 Sep 2026 → Aug 2028 expected apnea of prematurity, newborn respiratory distress syndrome, pulmonary immaturity UEA - Universidade Do Estado Do Amazonas Not yet recruiting No outcome recorded
Phase 4 NCT07168252 Dec 2025 → Dec 2026 expected Clare Hayes-Bradley Not yet recruiting No outcome recorded
Phase 4 NCT06029049 Sep 2023 → Jun 2025 overdue The University of Texas Health Science Center, Houston Recruiting No outcome recorded
Phase 4 NCT05562999 Nov 2022 → Aug 2024 Radboud University Medical Center Completed No outcome recorded
Phase 4 NCT05509192 Aug 2022 → Jan 2025 The University of Texas Health Science Center, Houston Completed No outcome recorded
Phase 4 NCT03643913 Dec 2018 → Nov 2024 arthropathy Universitaire Ziekenhuizen KU Leuven Completed No outcome recorded
Phase 4 NCT03572413 Oct 2018 → Aug 2020 Radboud University Medical Center Completed No outcome recorded
Phase 4 NCT03608436 Oct 2018 → Mar 2021 Radboud University Medical Center Completed No outcome recorded
Phase 4 NCT03646266 Aug 2018 → Dec 2020 respiratory failure Amsterdam UMC, location VUmc Unknown No outcome recorded
Phase 4 NCT03543826 May → Nov 2018 myopathy University of Washington Completed No outcome recorded
Phase not applicable52 trials
NCT07627750 Jun 2026 → Dec 2028 expected Bach Mai Hospital Not yet recruiting No outcome recorded
NCT07464288 Mar → Apr 2026 overdue Ankara City Hospital Bilkent Not yet recruiting No outcome recorded
NCT07035301 Mar → Jul 2025 respiratory system disorder Harbin Medical University Completed No outcome recorded
NCT06553066 Aug 2024 → Aug 2026 overdue University Hospital of Patras Not yet recruiting No outcome recorded
NCT05909696 Jul → Oct 2023 curariform drugs toxicity Yangzhou University Completed No outcome recorded
NCT05279898 Feb 2023 → Jun 2024 delirium Beth Israel Deaconess Medical Center Completed No outcome recorded
NCT05453929 Sep 2021 → Dec 2024 vertebral column disorder Korea University Guro Hospital Completed No outcome recorded
NCT04924621 Jun 2021 → May 2022 substance withdrawal syndrome Peking University Unknown No outcome recorded
NCT04821817 Apr 2021 → Feb 2025 strabismus Tanta University Completed No outcome recorded
NCT04768400 Mar 2021 → May 2022 brain neoplasm Gangnam Severance Hospital Completed No outcome recorded
Also used as a comparator or background therapy in 178 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 03 trials
Phase 0 NCT06720285 Background Oct → Nov 2023 Universitas Airlangga Completed No outcome recorded
Phase 0 NCT05294926 Comparator Apr 2022 → Jan 2023 Assiut University Unknown No outcome recorded
Phase 0 NCT04016740 Background Aug 2019 → Feb 2020 coronary artery disorder, delirium Beth Israel Deaconess Medical Center Completed No outcome recorded
Phase 12 trials
Phase 1 NCT07603596 Background May 2026 → Apr 2028 expected delirium, digestive system neoplasm Qianfoshan Hospital Not yet recruiting No outcome recorded
Phase 1 NCT02888067 Comparator Jul 2017 → Jul 2022 Thomas Schricker Terminated No outcome recorded
Phase 211 trials
Phase 2 NCT07595393 Background Aug 2026 → Jun 2027 expected curariform drugs toxicity Amckaus PTY LTD. Not yet recruiting No outcome recorded
Phase 2 NCT07404579 Comparator Mar → May 2026 Jiangsu HengRui Medicine Co., Ltd. Completed No outcome recorded
Phase 2 NCT05687253 Comparator Oct 2022 → Apr 2023 Baudax Bio Completed No outcome recorded
Phase 2 NCT03904550 Comparator Dec 2019 → Aug 2022 impaired renal function disease University of Texas Southwestern Medical Center Completed No outcome recorded
Phase 2 NCT03448068 Background Apr 2018 → Jan 2020 Mayo Clinic Completed No outcome recorded
Phase 2/33 trials
Phase 2/3 NCT03367988 Background Dec 2018 → Jan 2023 drug dependence University of South Florida Unknown No outcome recorded
Phase 2/3 NCT02393664 Comparator Mar 2015 → Oct 2016 lung neoplasm National Taiwan University Hospital Unknown No outcome recorded
Phase 2/3 NCT02147054 Comparator May 2014 → Jul 2016 organophosphate poisoning University of Edinburgh Completed No outcome recorded
Phase 317 trials
Phase 3 NCT07299630 Background Dec 2025 → May 2026 Ain Shams University Completed No outcome recorded
Phase 3 NCT06873906 Comparator Mar 2025 → Mar 2026 overdue heart septal defect Ain Shams University Not yet recruiting No outcome recorded
Phase 3 NCT05958589 Background Jan 2022 → Jul 2024 University of Novi Sad Completed No outcome recorded
Phase 3 NCT04581395 Comparator Oct 2020 → Apr 2023 Indiana University Completed No outcome recorded
Phase 3 NCT03960801 Comparator Oct 2019 → Apr 2021 Nantes University Hospital Completed No outcome recorded
Phase 473 trials
Phase 4 NCT06564857 Comparator Nov 2025 → Apr 2027 expected Nordsjaellands Hospital Recruiting No outcome recorded
Phase 4 NCT07203287 Comparator Aug 2025 → Dec 2026 expected The University of Texas Medical Branch, Galveston Recruiting No outcome recorded
Phase 4 NCT07044193 Comparator Jun 2025 → Dec 2028 expected curariform drugs toxicity Tamas Vegh, MD Not yet recruiting No outcome recorded
Phase 4 NCT07044180 Comparator Jun 2025 → Dec 2028 expected curariform drugs toxicity Tamas Vegh, MD Active not recruiting No outcome recorded
Phase 4 NCT06399445 Comparator Apr 2024 → Jun 2025 University Hospital of Split Unknown No outcome recorded
Phase not applicable69 trials
NCT07486336 Comparator Sep 2026 → Sep 2028 expected cognitive disorder Ente Ospedaliero Ospedali Galliera Not yet recruiting No outcome recorded
NCT07680400 Comparator Jul → Aug 2026 overdue Bezmialem Vakif University Not yet recruiting No outcome recorded
NCT07485517 Comparator Jun → Dec 2026 expected Menoufia University Not yet recruiting No outcome recorded
NCT07271472 Background Dec 2025 → May 2026 Ataturk University Completed No outcome recorded
NCT07192549 Background Sep 2025 → Sep 2030 expected delirium General Hospital of Ningxia Medical University Not yet recruiting No outcome recorded

Evidence & citations 20 cited values

Every value below carries the sentence it was read from. 296 sources stand behind the page.

FieldValueCited text
Known as Rocuronium Rocuronium and cisatracurium are representative neuromuscular blocking agents used widely because the former have features of fast onset of peak effect and short duration of...” NCT02495038
263

“When participants reach the titration endpoint (OAAS score 1 point) during the titration of propofol in the induction, the investigators stop the dosing and switch to a...” NCT04595591

“Maintenance of anesthesia will be achieved by isoflurane at an end tidal concentration of 1-1.5% in FiO2 of 0.5, intravenous fentanyl at a dose of 1 µg/kg in incremental...” NCT06873906

“1-3 mg IV propofol 0.5 mg/kg IV Rocuronium + Fentanyl 2-3 mcg/kg + Morphine 0.1mg/kg IV Maintenance: Volatile anesthetic + High volume local anesthesia infiltration Bupivacaine...” NCT03176758

“The investigators therefore hypothesized that remifentanil could prolong the onset time of rocuronium, and evaluated the effect of remifentanil on the hemodynamic profiles...” NCT01030510

“Anesthetized patients (American Society of Anesthesiologists class 1-2) received 0.6 mg/kg rocuronium and were randomized to receive sugammadex (0.5, 1.0, 2.0, or 4.0 mg/kg) or...” PMID 19194156 Feb 2009

“Remimazolam 6mg/kg/h was pumped intravenously for 2.5 min, Sufentanil 0.5 μg/kg and rocuronium 0.6mg/kg were injected intravenously, and endotracheal intubation was performed 3...” NCT06775366

“Midazolam 0.03 mg/kg injection vein,Sufentanyl 0.5\~1 μg/kg, target controlled infusion of etomidate or propofol,after the consciousness of patients is lost, rocuronium...” NCT02644980

“Deep neuromuscular block will be induced by rocuronium bolus 1 mg/kg, maintained by a continuous infusion of rocuronium (0.6mg/kg/h), and titrated towards post-tetanic count (PTC) 1-2.” NCT04259112

“In addition to propofol as a hypnotic and rocuronium as a muscle relaxant, patients in the conventional opioid-based group will receive the following drugs: Remifentanil and Fentanyl” NCT05485480

“General anesthesia will be induced with fentanyl 1,5 mcg/kg, propofol 2 mg/kg, rocuronium 0,6 mg/kg; after intubation anesthesia will be mantained with sevoflurane (MAC 1).” NCT04294537

“Propofol 1,5mg/Kg, supplemented by fentanyl 2mcg/Kg and rocuronium 0,5mg/Kg and O2 100% will be for induction to anesthesia and facilitate endotracheal intubation. .” NCT04802122

Rocuronium will be maintained in a arm 1) deep neuromuscular block group or arm 2) moderate neuromuscular block group (control group) according to the assignment.” NCT03937440

“Induction agents will be administered as quick boluses (Propofol 2,5mg/kg total body weight, max 350mg, Fentanyl 250mcg, Rocuronium 1,2mg/kg ideal body weight).” NCT03239236

“Anesthetic agents, including propofol, fentanyl, rocuronium, and sevoflurane, were used as part of standard anesthetic management during the procedure.” NCT07370779

“General anesthesia induction will be performed with fentanyl 1-2 μg/kg, propofol 2-3 mg/kg, and rocuronium 0.6 mg/kg and maintained with sevoflurane.” NCT06584695

“Induction with 1% propofol (2-3 mg/kg), fentanyl (1-3 mg/kg), and Rocuronium 1-1.5 mg/kg. Before the injection of propofol, 5 mL 1% lidocaine (50 mg)” NCT04281017

“Standardized general anaesthesia with fentanyl 2 mcg/kg ABW at induction, propofol 1.5 mg/kg, rocuronium 0.6 mg/kg, sevoflurane 1 MAC for maintenance” NCT07299630

“Patients assigned to MTPI will then be given rocuronium (0.6mg/kg), followed by propofol intravenously as a single bolus within 10 seconds.” NCT05509192

Rocuronium 0.3 mg kg-1 was injected at I.V. line to patients (R 0.3 group), as muscle relaxants during anesthesia for adenotonsillectomy.” NCT02467595

“To maintain TOF at 2 and according to our practice a bolus injection of 0,1 mg/kg Rocuronium will be given when TOF count returns to 3.” NCT03643913

“The first one included DNMB with a rocuronium bolus at the starting dose of 1.2 mg/kg and a maintenance dose (0.3-0.6 mg/kg/h).” PMID 37386582 Jan 2023

“Remimazolam, sufentanil and rocuronium were used during induction, and remimazolam and refentanil were used during maintenance” NCT06990763

“Induction was carried out by fentanyl 3mcg/kg, propofol 2 mg/kg and rocuronium at the dose of 1mg/kg to facilitate intubation” NCT05417529

“Anaesthesia induction will be obtained with i.v. 2-3 mg/kg propofol, 0,6-0,8 mcg/kg fentanyl, and 0.9-1,2 mg/kg rocuronium.” NCT03157479

“Anesthesia induction will include 2 mg midazolam, 2-2.5 mg/kg propofol, 0.6-0.9 mg/kg rocuronium, and 1 μg/kg remifentanil.” NCT07271472

“Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count” NCT03170661

“Anesthesia induction with rocuronium 0.4mg/kg and maintenance with rocuronium 0.15mg/kg to maintain TOF 1-2 twitch” NCT02249585

Rocuronium will be used for muscle relaxation in order to achieve the necessary depth of neuromuscular blockade.” NCT02794714

“Intubation is performed 3 minutes after administration of remifentanil 1-2 mcg / kg and rocuronium 0.6 mg / kg.” NCT03447691

“anaesthesia will be induced with 1.5-2.5 mg/kg propofol, 0.3-0.5 mg/kg esketamine, and 0.6-1.0 mg/kg rocuroniumNCT07603596

“muscle paralysis may be achieved with succinylcholine or non-depolarizing paralytic (rocuronium or vecuronium)” NCT03263117

“patients in group C will receive fentanyl 1 μg/kg, propofol 2.5 mg/kg, and rocuronium 0.3 mg/kg intravenously” NCT07680400

“All patients were induced with individual intravenous doses of midazolam, rocuronium, fentanyl and propofol.” NCT02399397

“lidocaine (1mg/kg), esketamine (0.5mg/kg), propofol (1-2mg/kg) and rocuronium (0.6mg/kg) were infused slowly” NCT05577962

“In this case the use of another neuromuscular blockade, Rocuronium (ESMERON), is an alternative solution.” NCT03960801

“Patients in this group receive 0.06mg/kg of rocuronium before administration of 0.54mg/kg of rocuronium.” NCT01389791

“Anesthesia was induced by sequential intravenous injection of remimazolam, sufentanil, and rocuronium.” NCT07192549

“General anesthesia with Lidocaine 1.5mg/kg, Fentanyl 2 mcg/kg, propofol 2 mg/kg, Rocuronium 0.6 mg/kg” NCT06892600

“standard care group which uses Rocuronium (NMBA) as an adjunct for maintenance of general anesthesia” NCT03962725

“Anesthesia will be induced with rocuronium 1mg, propofol 3-6 mg/kg, and succinylcholine 1.5 mg/kg” NCT03367988

“General anesthesia using classical GABAergic-drugs such as propofol, remifentanil and rocuronium.” NCT07486336

“Continuous Rocuronium (Rocnium®, Hanlim Pharm. Co., Ltd., South Korea) infusion during surgery” NCT03871387

“Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation in Adults” NCT07252921

Rocuronium dose will be infused to maintain a depth of NMB to PTC 1\~2 intraoperatively” NCT01804933

rocuronium will be given as 0.2 mg/kg to maintain a post-tetanic count (PTC) of \>1” NCT07485517

“neuromuscular blockade will be performed using a continuous infusion of rocuronium.” NCT02762890

“Neuromuscular blockade was performed during the operation by rocuronium infusion” NCT03946657

“Deep neuromuscular block using high dose rocuronium and 8 mmHg pneumoperitoneum” NCT03576118

“Standard neuromuscular block provided by rocuronium to TOF-count 1-2.” NCT02513693

“0.6 mg/kg rocuronium was administered to facilitate intubation.” NCT06958913

“Cisatracurium 0.2mg/kg or alternatively Rocuronium 0.6-1.2mg/kg” NCT04894864

“fentanyl (1-2 mcg/kg) and rocuronium (0.1mg/kg) and maintained” NCT01566838

“intravenous rocuronium after induction of general anesthesia” PMID 33537703 Jun 2021

“Neuromuscular blockade will be performed using rocuronium.” NCT04768400

“neuromuscular block w/succinylcholine and/or rocuroniumNCT03448068

“1.2 mg/kg rocuronium once IV access is established” NCT03408340

“Group I (n = 58) received rocuronium 0.6 mg/kg.” PMID 40542414 Jun 2025

“esketamine 0.5 mg kg-1, rocuronium 0.6-1mg kg-1” NCT06493396

“Using rocuronium and reversal with sugammadex” NCT02648503

“Cisatracurium or alternatively RocuroniumNCT05172739

“* Rocuronium for neuromuscular blockade,” NCT07337135

Rocuronium 0.3 - 0.9mg/kg intravenously” NCT01511627

“Pentothal 4mg/kg Rocuronium 0.6 mg/kg” NCT01518608

rocuronium (0.4 \~ 0.6 mg / kg)” NCT04063046

“Muscle relaxant (rocuronium)” NCT03299621

Rocuronium and Sugammadex” NCT06553066

Rocuronium 1 mg/kg i.v.” NCT02902055

rocuronium 0.6-1mg kg-1” NCT06305221

rocuronium 0.6mg/kg iv” NCT06120439

“0,9-1 mg/kg RocuroniumNCT07568938

Rocuronium 0.9mg/kg” NCT01474252

RocuroniumNCT04512313

ROCURONIUMNCT02004015

NCT02631135

NCT03795259

NCT00298831

NCT03043157

NCT02669368

NCT02064140

NCT02000674

NCT03135795

NCT03013036

NCT02247466

NCT04287426

NCT00656799

NCT05468671

NCT01631149

NCT02553629

NCT07464288

NCT02518789

NCT02147054

NCT03266419

NCT00475215

NCT06679569

NCT02703909

NCT02769325

NCT00926718

NCT00474253

NCT05919732

NCT03270696

NCT04035707

NCT03529201

NCT01930747

NCT01035021

NCT05909696

NCT07168252

NCT02539706

NCT02393664

NCT03904550

NCT02589691

NCT03138967

NCT03287388

NCT02698969

NCT02711917

NCT01851005

NCT06720285

NCT01824758

NCT02696837

NCT03039543

NCT03434678

NCT02484651

NCT02575443

NCT03890406

NCT01450813

NCT03910998

NCT00953550

NCT04868409

NCT04510337

NCT00724932

NCT05423951

NCT03487003

NCT03602469

NCT01571908

NCT02709473

NCT02118844

NCT02778945

NCT04821817

NCT02724111

NCT05453929

NCT03910504

NCT02471521

NCT03009877

NCT02194855

NCT00552617

NCT01849211

NCT03830086

NCT02134093

NCT01683006

NCT04512313

NCT02025075

NCT00124735

NCT01996358

NCT07064408

NCT07595393

NCT01651572

NCT03226080

NCT01722097

NCT03540030

NCT02546843

NCT06150001

NCT00473694

NCT03596060

NCT02141737

NCT05279898

NCT05543109

NCT01902641

NCT07404579

NCT01564576

NCT01199237

NCT00675792

NCT05596227

NCT01728584

NCT04581395

NCT02237443

NCT06029049

NCT02079337

NCT04760912

NCT04236050

NCT01719770

NCT07092046

NCT01441960

NCT00751179

NCT02657187

NCT02140593

NCT01748643

NCT05887375

NCT02266056

NCT07650552

NCT02185339

NCT02318810

NCT02880787

NCT03791801

NCT02109510

NCT01962298

NCT05725031

NCT01550354

NCT03346057

NCT03391700

NCT00559468

NCT01479751

NCT02036827

NCT06707532

NCT02414880

NCT02109133

NCT02469831

NCT03369782

NCT02464722

NCT01749501

NCT02785653

NCT04709315

NCT04924621

NCT01933425

NCT03808077

NCT02601508

NCT00540085

NCT01591031

NCT03346070

NCT05687253

NCT01436799

NCT03543826

NCT01937767

NCT00355368

NCT07035301

NCT06564857

NCT01690338

NCT02646709

NCT01532466

NCT02451202

NCT04872881

NCT01523886

NCT05294926

NCT03031808

NCT01718236

NCT03532178

NCT04016740

NCT07627750

NCT03658057

NCT01941628

NCT02054468

NCT02634255

NCT02410590

NCT03939923

NCT07203287

NCT02260258

NCT02320734

NCT05602519

NCT05097508

NCT01579864

NCT02642367

NCT02400931

NCT01672606

NCT02289586

NCT02812186

NCT03318718

NCT04105764

NCT03726372

NCT02486926

NCT02953210

NCT05689957

NCT03958201

NCT00970762

NCT06225466

NCT07033442

Known as Bromure de rocuronium ChEMBL registry synonym — accepted as the source's own label CHEMBL1201244
Known as Bromuro de rocuronio ChEMBL registry synonym — accepted as the source's own label CHEMBL1201244
Known as Esmeron “Drug: Rocuronium Intravenous use: 0.3 mg/kg before intubation and 0,7 mg after intubation followed by infusion with 0,3-0,4 mg/kg/h Other Name: EsmeronNCT01722097
8

“During the ablation performed, the patient will be under the influence of a muscle relaxant from the non-depolarising group (rocuronium, Esmeron®).” NCT06707532

“In this case the use of another neuromuscular blockade, Rocuronium (ESMERON), is an alternative solution.” NCT03960801

“rocuronium bromide (Zemuron®, Esmeron®)” NCT01564576

“0.6 mg/kg Rocuronium bromide (esmeron)” NCT06399445

“Rocuronium (Esmeron):” NCT01651572

NCT03519854

NCT00535743

NCT02790164

Known as Org 9426 “Rocuronium bromide (Org 9426)” NCT00984633
Known as ROC “This study aims to evaluate the influence of age and sepsis on in vivo activity of OATP1A2 using rocuronium (ROC) as a probe and evaluating the pharmacokinetics and...” NCT02399397
Known as Rocnium “Continuous Rocuronium (Rocnium®, Hanlim Pharm. Co., Ltd., South Korea) infusion during surgery” NCT03871387
Known as rocunium “Deep neuromuscular block with 'rocunium®'” NCT03937440
Known as Rocuronbromid ClinicalTrials.gov intervention name — accepted as the source's own label NCT00527332
Known as rocuronium bromide “BACKGROUND: Succinylcholine remains the muscle relaxant of choice for rapid sequence induction (RSI) but has many adverse effects. High-dose rocuronium bromide may be an...” PMID 33337797 Dec 2021
32

“Induction of anesthesia will be the same for all patients and consist of intravenous anesthetic propofol (2-3 mg/kg), opioid analgesic fentanyl (1-1.5 mcg/kg), and muscle...” NCT05958589

“To achieve NMB, participants received steroidal NMBA Rocuronium Bromide or Vecuronium Bromide administered via i.v. infusion and dosed according to participant ABW.” NCT03346070

“participants received steroidal NMBA Rocuronium Bromide administered via IV infusion and dosed according to participant body weight.” NCT03346057

“Propofol, Atracurium Besilate or Cisatracurium besylate or Rocuronium BromideNCT04553536

rocuronium bromide (Zemuron®, Esmeron®)” NCT01564576

Rocuronium BromideNCT05687253

Rocuronium bromideNCT04760912

Rocuronium bromideNCT01142635

NCT02827435

NCT03572413

NCT06399445

NCT07044180

NCT03669484

NCT07044193

NCT03424356

NCT03646266

NCT05562999

NCT05872451

NCT03060707

NCT00124722

NCT03881423

NCT00984633

NCT03591289

NCT00988520

NCT05619848

NCT03825198

NCT03608436

NCT03782233

NCT02467595

NCT02586441

NCT00421148

NCT02888067

Known as Rocuronium bromide: Zemuron Rocuronium bromide: ZemuronNCT01450813
Known as Rocuronium cation ChEMBL registry synonym — accepted as the source's own label CHEMBL1201244
Known as Rocuronium Injectable Solution “Drug: Rocuronium Injectable SolutionNCT02953210
Known as Rocuronium ion ChEMBL registry synonym — accepted as the source's own label CHEMBL1201244
Known as Rocuronium, Esmeron Rocuronium, EsmeronNCT02794714
1

“rocuronium: Esmeron” NCT01748643

Known as Zemuron “Rocuronium: Zemuron. Sugammadex: Bridion. Succinylcholine: Suxamethonium” NCT03532178
2

“rocuronium bromide (Zemuron®, Esmeron®)” NCT01564576

NCT03519867

Known as Zemuron Injection (rocuronium bromide) “Zemuron® Injection (rocuronium bromide)” NCT00751179
1

“Zemuron® Injection (rocuronium bromide)” NCT01728584

Action Inhibit “By binding free rocuronium, less rocuronium becomes available at the neuromuscular junction to bind to the muscarine receptor. Non-depolarizing neuromuscular blocking agents...” NCT01631149
Modality Other / unclassified “two commonly used neuromuscular blocking agents (succinylcholine and rocuronium)” NCT01441960
Route Intravenous “A single IV Zemuron bolus dose of 0.45 mg/kg prior to intubation.” NCT00124722